AIMS: To evaluate whether there is a correlation between the subcellular localization of maspin and the histological, molecular and biological features of pulmonary adenocarcinoma, particularly addressing the hypothesis that the tumour inhibitor properties of maspin may be linked to a nuclear, compared with a combined nuclear and cytoplasmic expression pattern. METHODS AND RESULTS: The subcellular expression of maspin was determined in 80 resected pulmonary adenocarcinomas (Stage I, 46; Stage II, 10; Stage III, 20; Stage IV, 4) and correlated with histological grade, proliferative rate, p53 expression, vascular endothelial growth factor (VEGF)-A levels, and prognosis (mean follow-up of 41.5 months). Cases with nuclear (N) maspin (n = 47), compared with the [N + cytoplasmic (C)] group (n = 28), showed lower (P <or= 0.05): histological grade, proliferative rate, p53 expression and VEGF-A levels. Cox multivariate analysis revealed in stage I adenocarcinomas (N) maspin as the only predictor of improved survival. CONCLUSIONS: (N) maspin selects lung adenocarcinomas with distinct molecular and clinical features, supporting the hypothesis that its tumour inhibitor properties may be linked to its nuclear localization.
AIMS: To evaluate whether there is a correlation between the subcellular localization of maspin and the histological, molecular and biological features of pulmonary adenocarcinoma, particularly addressing the hypothesis that the tumour inhibitor properties of maspin may be linked to a nuclear, compared with a combined nuclear and cytoplasmic expression pattern. METHODS AND RESULTS: The subcellular expression of maspin was determined in 80 resected pulmonary adenocarcinomas (Stage I, 46; Stage II, 10; Stage III, 20; Stage IV, 4) and correlated with histological grade, proliferative rate, p53 expression, vascular endothelial growth factor (VEGF)-A levels, and prognosis (mean follow-up of 41.5 months). Cases with nuclear (N) maspin (n = 47), compared with the [N + cytoplasmic (C)] group (n = 28), showed lower (P <or= 0.05): histological grade, proliferative rate, p53 expression and VEGF-A levels. Cox multivariate analysis revealed in stage I adenocarcinomas (N) maspin as the only predictor of improved survival. CONCLUSIONS: (N) maspin selects lung adenocarcinomas with distinct molecular and clinical features, supporting the hypothesis that its tumour inhibitor properties may be linked to its nuclear localization.
Authors: Fulvio Lonardo; Konstantin H Dragnev; Sarah J Freemantle; Yan Ma; Natalie Memoli; David Sekula; Elisabeth A Knauth; Jean S Beebe; Ethan Dmitrovsky Journal: Clin Cancer Res Date: 2002-01 Impact factor: 12.531
Authors: H Han; J F Silverman; T S Santucci; R S Macherey; T A d'Amato; M Y Tung; R J Weyant; R J Landreneau Journal: Ann Surg Oncol Date: 2001 Jan-Feb Impact factor: 5.344
Authors: Anil K Sood; Mavis S Fletcher; Lynn M Gruman; Jeremy E Coffin; Sarvenaz Jabbari; Zhila Khalkhali-Ellis; Nancy Arbour; Elisabeth A Seftor; Mary J C Hendrix Journal: Clin Cancer Res Date: 2002-09 Impact factor: 12.531
Authors: Eva Juengel; Wolf-Dietrich C Beecken; Santhosh Mundiyanapurath; Tobias Engl; Dietger Jonas; Roman A Blaheta Journal: World J Urol Date: 2010-03-25 Impact factor: 4.226
Authors: Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng Journal: Mol Cancer Res Date: 2011-05-26 Impact factor: 5.852
Authors: Sijana H Dzinic; Kang Chen; Archana Thakur; Alexander Kaplun; R Daniel Bonfil; Xiaohua Li; Jason Liu; M Margarida Bernardo; Allen Saliganan; Jessica B Back; Hiroshi Yano; Dana L Schalk; Elyse N Tomaszewski; Ahmed S Beydoun; Gregory Dyson; Adelina Mujagic; David Krass; Ivory Dean; Qing-Sheng Mi; Elisabeth Heath; Wael Sakr; Lawrence G Lum; Shijie Sheng Journal: Oncotarget Date: 2014-11-30